Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Ann Ig ; 32(6): 682-688, 2020.
Article in English | MEDLINE | ID: mdl-33175078

ABSTRACT

BACKGROUND: The management of Latent Tuberculosis Infection is crucial in fighting Tuberculosis worldwide, and particularly in low incidence European Countries. While guidelines for the management of Tuberculosis in newly arrived immigrants have been issued by the European Center for Disease Control and Prevention and by the National Health Authorities in Italy, these are not widely implemented yet at local level. STUDY DESIGN: We report our program for the screening of Latent Tuberculosis Infection and active Tuberculosis in asylum seekers, jointly implemented by Public Health Authorities and the Infectious Diseases Department of a tertiary care, teaching hospital in Northern Italy. METHODS: We reviewed records of the asylum seekers who were screened at our center via Tuberculin Skin Test and/or Interferon Gamma Release Assay plus chest X-ray and either treated with Isoniazid Preventive Treatment or for active Tuberculosis Disease in case of positive results. RESULTS: We screened 726 migrants, mostly males (97.3%) and from Sub-Saharan Africa (82.2%) and found a high adherence rate for both screening (98.2%) and Isoniazid Preventive Treatment (90.1%). In addition, we found seven cases of active Tuberculosis. CONCLUSIONS: Latent Tuberculosis Infection screening and treatment proved feasible in our program, which should be systematically implemented in asylum seekers reaching Europe.


Subject(s)
Latent Tuberculosis/epidemiology , Mass Screening , Refugees , Adolescent , Adult , Africa South of the Sahara/ethnology , Algorithms , Antitubercular Agents/therapeutic use , Asia, Southeastern/ethnology , Bronchoalveolar Lavage Fluid/microbiology , Female , Humans , Interferon-gamma Release Tests , Isoniazid/therapeutic use , Italy/epidemiology , Latent Tuberculosis/diagnosis , Latent Tuberculosis/diagnostic imaging , Latent Tuberculosis/drug therapy , Male , Mass Screening/statistics & numerical data , Mediterranean Region/ethnology , Mycobacterium tuberculosis/isolation & purification , Patient Compliance , Prevalence , Program Evaluation , Retrospective Studies , Sputum/microbiology , Tuberculin Test , Young Adult
3.
Clin Microbiol Infect ; 26(8): 1094.e1-1094.e5, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32450255

ABSTRACT

OBJECTIVES: To detect possible severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA contamination of inanimate surfaces in areas at high risk of aerosol formation by patients with coronavirus disease 2019 (COVID-19). METHODS: Sampling was performed in the emergency unit and the sub-intensive care ward. SARS-CoV-2 RNA was extracted from swabbed surfaces and objects and subjected to real-time RT-PCR targeting RNA-dependent RNA polymerase and E genes. Virus isolation from positive samples was attempted in vitro on Vero E6 cells. RESULTS: Twenty-six samples were collected and only two were positive for low-level SARS-CoV-2 RNA, both collected on the external surface of continuous positive airway pressure helmets. All transport media were inoculated onto susceptible cells, but none induced a cytopathic effect on day 7 of culture. CONCLUSIONS: Even though daily contact with inanimate surfaces and patient fomites in contaminated areas may be a medium of infection, our data obtained in real-life conditions suggest that it might be less extensive than hitherto recognized.


Subject(s)
Betacoronavirus/growth & development , Fomites/virology , RNA-Dependent RNA Polymerase/genetics , Viral Envelope Proteins/genetics , Animals , Betacoronavirus/genetics , Chlorocebus aethiops , Coronavirus Envelope Proteins , Equipment Contamination , Humans , Intensive Care Units , Microbial Viability , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2 , Vero Cells , Viral Proteins/genetics
5.
Eur Rev Med Pharmacol Sci ; 19(5): 866-78, 2015.
Article in English | MEDLINE | ID: mdl-25807441

ABSTRACT

The lumen of the gastrointestinal tract is home to an enormous quantity of different bacterial species that thrive in an often symbiotic relationship with the host. It is the principal source of microbial products because of its massive bacterial load. Injury to the immune component of the gastrointestinal mucosal surface, along with damage to the intestinal epithelial microenvironment with its antimicrobial functions, may affect systemic immune activation during the chronic phase of HIV infection through the increased translocation of luminal microbial products. Moreover, microbial translocation, which is defined as "the passage of both viable and nonviable microbes and microbial products such as endotoxin across anatomically intact intestinal barrier", may be a fundamental mechanism through which HIV accelerates progression of chronic viral hepatitis. Improvements in the tools available to microbiota research, and especially advancement of our knowledge in this area may help us in controlling the evolution of HIV disease, although population complexity and diversity between individuals make this challenging.


Subject(s)
Gastrointestinal Tract/microbiology , HIV Infections/microbiology , Disease Progression , Gastrointestinal Tract/immunology , HIV Infections/immunology , Humans , Immunity, Mucosal/immunology , Intestinal Mucosa/immunology , Intestinal Mucosa/microbiology
6.
J Viral Hepat ; 19 Suppl 1: 33-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22233411

ABSTRACT

The pharmacokinetics and in dosing regimens of the currently available pegylated interferon (peginterferon) alfa molecules differ greatly, depending on the size and nature of their polyethylene glycol (PEG) moiety. Peginterferon alfa-2a has a branched 40 kDa PEG chain covalently attached to lysine residues and circulates as an intact molecule. On the other hand, peginterferon alfa-2b has a linear 12 kDa PEG chain covalently attached to interferon-a-2b via an unstable urethane bond that is hydrolysed after injection, releasing native interferon alfa-2b. The difference in pegylation between the two peginterferons has a significant impact on their pharmacokinetic properties. Data from comparative and non-comparative studies indicate that peginterferon alfa-2b has a shorter half-life in serum than peginterferon alfa-2a, and a significant proportion of patients receiving peginterferon alfa-2b may have trough concentrations below the limit of detection during the latter part of the 7-day dosing schedule. However, the pharmacodynamic parameters of the two drugs appear to be similar.


Subject(s)
Antiviral Agents/pharmacokinetics , Antiviral Agents/therapeutic use , Hepacivirus/drug effects , Interferon-alpha/pharmacokinetics , Interferon-alpha/therapeutic use , Polyethylene Glycols/pharmacokinetics , Polyethylene Glycols/therapeutic use , Antiviral Agents/pharmacology , Clinical Trials as Topic , Drug Therapy, Combination , Half-Life , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/virology , Humans , Interferon alpha-2 , Interferon-alpha/pharmacology , Polyethylene Glycols/pharmacology , Recombinant Proteins/pharmacokinetics , Recombinant Proteins/pharmacology , Recombinant Proteins/therapeutic use , Ribavirin/therapeutic use , Treatment Outcome
7.
Neurol Sci ; 32(5): 833-9, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21630038

ABSTRACT

The introduction of highly active antiretroviral therapy does not seem to have altered the incidence of progressive multifocal leukoencephalopathy (PML) in HIV infection. Moreover, the occurrence of a HIV-related leukoencephalopathy, called not determined leukoencephalopaties (NDLE), has been reported. As neuropsychological impairment remains highly prevalent in HIV infection, the aim of this study is to describe the neuropsychological profile of PML and NDLE patients, analyzing the time-related changes. Clinical and neuropsychological data from 32 patients (17 PML, 15 NDLE) were compared with two control groups: (1) asymptomatic HIV+ patients without magnetic resonance imaging evidence of leukoencephalopathy; (2) age-/gender-/education-matched healthy subjects. Patients with rapidly worsening PML were significantly impaired on all neuropsychological tests, while PML with more benign course and NDLE groups showed a dysexecutive pattern of impairment. Asymptomatic HIV+ subjects showed mild and isolated cognitive deficits, without functional impact. Cognitive impairment should therefore be considered a key feature from HIV infection diagnosis.


Subject(s)
HIV Infections/psychology , JC Virus/isolation & purification , Leukoencephalopathy, Progressive Multifocal/psychology , Adult , Aged , Antiretroviral Therapy, Highly Active , Female , HIV Infections/drug therapy , HIV Infections/virology , Humans , Leukoencephalopathy, Progressive Multifocal/drug therapy , Leukoencephalopathy, Progressive Multifocal/virology , Male , Middle Aged , Neuropsychological Tests
8.
Infection ; 36(3): 244-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18454340

ABSTRACT

BACKGROUND: There is very less information on the use of antiretroviral (ARV) drugs and viro-immunological outcome over calendar years in Italy. PATIENTS AND METHODS: We performed an analysis of a prospective observational cohort (MASTER) to assess antiretroviral drug use in first line HAART and explore whether initial treatment response changed over the years. RESULTS: 3,648 ARV-naive patients with available HIV-RNA and CD4+ T cell count at baseline who started their first HAART between 1997 and 2004 were studied. Mean age was 37.7 years; they were mostly males (72.3%) and Italians (81.4%). Prescription of non-nucleoside reverse transcriptase inhibitors and protease inhibitors boosted with ritonavir rose from 0.3% in 1997 to 58% in 2004 and from 0.3%in 1997 to 33.4% in 2004, respectively. Virological failures decreased over calendar years: from 42.9% in 1997 to 8.1%in 2004 after 6 months of HAART (p<0.001); from 42.1%(1997) to 10.7% (2004) after 12 months (p<0.001) and; from 39.5% (1997) to 8.2% (2004) after 18 months (p<0.001). The same trend, but less striking, was found for immunological failure rates. CONCLUSIONS: In the general Italian population of HIV-positive patients, evolution of treatment prescription correlated with improved viro-immunological outcome.


Subject(s)
Anti-HIV Agents/therapeutic use , Drug Administration Schedule , HIV Infections/drug therapy , Reverse Transcriptase Inhibitors/therapeutic use , Adult , Anti-HIV Agents/administration & dosage , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , Cohort Studies , Drug Therapy, Combination , Female , HIV Infections/immunology , HIV Infections/virology , Humans , Italy , Longitudinal Studies , Male , RNA, Viral/blood , Reverse Transcriptase Inhibitors/administration & dosage , Treatment Failure , Treatment Outcome
9.
J Med Virol ; 76(3): 311-7, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15902712

ABSTRACT

A cross-sectional study was undertaken on the correlates of infection for the human immunodeficiency virus (HIV) and hepatitis viruses B and C (HBV and HCV) in a sample of inmates from eight Italian prisons. A total of 973 inmates were enrolled [87.0% males, median age of 36 years, 30.4% intravenous drug users (IDUs), 0.6% men who have sex with men (MSWM)]. In this sample, high seroprevalence rates were found (HIV: 7.5%; HCV: 38.0%; anti-HBc: 52.7%; HBsAg: 6.7%). HIV and HCV seropositivity were associated strongly with intravenous drug use (OR: 5.9 for HIV; 10.5 for HCV); after excluding IDUs and male homosexuals, the HIV prevalence remained nonetheless relatively high (2.6%). HIV prevalence was higher for persons from Northern Italy and Sardinia. The age effect was U-shaped for HIV and HCV infections; HBV prevalence increased with age. Tattoos were associated with HCV positivity (OR: 2.9). The number of imprisonments was associated with HIV infection, whereas the duration of imprisonment was only associated with anti-HBc. The probability of being HIV-seropositive was higher for HCV-seropositive individuals, especially if IDUs. In conclusion, a high prevalence of HIV, HCV, and HBV infections among inmates was observed: these high rates are in part attributable to the high proportion of IDUs. Frequency of imprisonment and tattoos were associated, respectively, with HIV and HCV positivity. Although it is possible that the study population is not representative of Italy's prison inmate population, the results stress the need to improve infection control measures users was prisons.


Subject(s)
HIV Infections/epidemiology , Hepatitis B/epidemiology , Hepatitis C/epidemiology , Prisoners , Adult , Age Factors , Cross-Sectional Studies , Female , HIV Antibodies/blood , HIV Infections/complications , Hepatitis B/complications , Hepatitis B Antibodies/blood , Hepatitis B Surface Antigens/blood , Hepatitis C/complications , Hepatitis C Antibodies/blood , Homosexuality, Male , Humans , Italy/epidemiology , Male , Middle Aged , Risk Factors , Substance Abuse, Intravenous/complications , Tattooing , Time Factors
12.
Parassitologia ; 39(4): 437-9, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9802109

ABSTRACT

From small subunit ribosomal RNA gene sequences, a pair of PCR primers were designed to amplify a portion of this gene from five species of microsporidia. The amplified fragments encompass polymorphic restriction sites for the Hphl enzyme, resulting in different restriction patterns in the different species. We tested this identification method both on cultured microsporidia and on clinical samples. On cultured microsporidia the expected amplification bands were obtained even when DNA preparations from only ten spores were analysed. On clinical samples, identification of microsporidia was obtained from crude DNA preparations. This method allows for a rapid and easy diagnosis of human microsporidioses.


Subject(s)
AIDS-Related Opportunistic Infections/parasitology , Microsporida/isolation & purification , Microsporidiosis/parasitology , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , AIDS-Related Opportunistic Infections/diagnosis , Animals , DNA Primers , DNA, Protozoan/genetics , Humans , Microsporida/classification , Microsporida/parasitology , Microsporidiosis/diagnosis , Species Specificity
13.
Parasite ; 3(2): 183-5, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8758555

ABSTRACT

Pneumocystis carinii pneumonia (PCP) is a highly frequent cause of morbidity and mortality in immunocompromised subjects, particularly in HIV-infected ones. The biology of P. Carinii is poorly understood because of the lack of reliable synthetic media or adequate cell lines to grow this opportunistic pathogen in continuous culture. We reported the suitability of the MDCK (Madin Darby Canine Kidney, ATTC CCL 34) cell line to support the temporary microorganism's growth in vitro and the experimental pharmacological trials, in comparison with the HEL 299 cell line, used as reference standard.


Subject(s)
Cell Line , Cells, Cultured , Pneumocystis , Animals , Dogs , Pneumocystis/growth & development , Rats
14.
Parasitology ; 112 ( Pt 4): 363-9, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8935948

ABSTRACT

Since 1993, strains of Entamoeba histolytica sensu lato have been assigned to 2 species on the basis of clinical, biochemical, immunological and genetic evidence: the pathogenic strains to E. histolytica sensu stricto, the non-pathogenic strains to Entamoeba dispar. Analysis of the gene encoding for the small subunit ribosomal RNA (SSU rDNA) supports the existence of 2 species. However, while 3 whole SSU rDNA sequences are available in the data bases for E. histolytica, only a partial sequence has been published for E. dispar. Here we report a SSU rDNA sequence for E. dispar. Compared to those of E. histolytica, this sequence shows 1.7% nucleotide substitutions. On the basis of our rDNA data, 2 primers were designed to produce polymerase chain reaction (PCR) amplification from both E. histolytica and E. dispar. Primer specificity for the 2 amoebae was assessed both theoretically against the data bases, and experimentally against a collection of eukaryotic and prokaryotic DNAs. The amplified stretch encompasses a polymorphic Dde I restriction site which allows, after cleavage of the fragment, E. histolytica and E. dispar to be distinguished. The reliability of this method of identification was assessed comparing the results with those based on classic isoenzyme analysis.


Subject(s)
DNA, Protozoan/genetics , DNA, Ribosomal/genetics , Entamoeba histolytica/genetics , Entamoeba/genetics , Polymorphism, Restriction Fragment Length , Animals , Base Sequence , DNA Primers , Genes, Protozoan/genetics , Molecular Sequence Data , Polymerase Chain Reaction/methods , RNA, Protozoan/genetics , RNA, Ribosomal/genetics , Sequence Analysis, DNA , Species Specificity
15.
Trans R Soc Trop Med Hyg ; 89(4): 403-5, 1995.
Article in English | MEDLINE | ID: mdl-7570880

ABSTRACT

A limited outbreak of symptomatic intestinal and extraintestinal amoebiasis within a family complex is described. The infection was almost certainly transmitted by a Philippino housemaid, who was an asymptomatic carrier of Entamoeba histolytica infection acquired in her native country. Starch-gel electrophoresis showed isoenzyme patterns characteristic of pathogenic zymodeme XIX in all the amoebic isolates.


Subject(s)
Entamoeba histolytica/isolation & purification , Entamoebiasis/transmission , Adult , Animals , Antiprotozoal Agents/therapeutic use , Child , Disease Outbreaks , Drug Therapy, Combination , Entamoebiasis/drug therapy , Female , Humans , Italy , Male , Metronidazole/therapeutic use
16.
Parasitol Res ; 81(2): 148-51, 1995.
Article in English | MEDLINE | ID: mdl-7731923

ABSTRACT

A total of 77 mentally retarded male inpatients residing in a psychiatric institution in northern Italy were screened for the presence of stool parasites, Entamoeba histolytica particularly. Parasitological stool examination showed Entamoeba spp. (E. histolytica and/or E. dispar) in 26 cases (33.7%). In vitro culture on Robinson's medium was positive in 16 cases (61.1%); in 11 cases we could stabilize and clone the isolates and proceed to electrophoretic assays. In all cases, patterns of pathogenic zymodemes were found (zymodeme II, 3 isolates; zymodeme XII, 4 isolates; zymodeme XIV, 4 isolates). All isolates were therefore identified as E. histolytica.


Subject(s)
Dysentery, Amebic/epidemiology , Entamoeba histolytica/isolation & purification , Entamoeba/isolation & purification , Adult , Aged , Animals , Dysentery, Amebic/diagnosis , Entamoeba/classification , Entamoeba/enzymology , Entamoeba histolytica/classification , Entamoeba histolytica/enzymology , Feces/parasitology , Female , Hexokinase/analysis , Hospitals, Psychiatric , Humans , Inpatients , Italy , Malate Dehydrogenase/analysis , Male , Phosphoglucomutase/analysis
17.
Parassitologia ; 36(3): 265-7, 1994 Dec.
Article in Italian | MEDLINE | ID: mdl-7637995

ABSTRACT

We report a case of a tourist, coming back from Tanzania, who presented with a foruncle on the left thigh diagnosed as a bacterial infection, which eventually turned out to be a myiasis foruncle. The patient said he had sat on the ground in short trousers. The lesion was covered with petroleum jelly and the larva was observed migrating from the lesion and subsequently extracted with forceps. The morphology of larval spiracles allowed to characterize the species as Cordylobia anthropophaga. Behaviour of the most common myiasis-producing flies, their life cycle and the way of infection are briefly described. Foruncular myiasis is a typical example of a tropical disease that can be misdiagnosed by clinicians in Western Countries where this pathology is uncommon.


Subject(s)
Myiasis/parasitology , Adult , Animals , Diptera/growth & development , Diptera/ultrastructure , Furunculosis/etiology , Humans , Italy , Larva/ultrastructure , Male , Tanzania , Travel
18.
Parasite ; 1(4): 387-90, 1994 Dec.
Article in English | MEDLINE | ID: mdl-9140503

ABSTRACT

Cyclospora is recently described new human pathogenic coccidian causing intermittent diarrhoeal enteritis which may persist for weeks or months in immunocompetent subjects, particularly travellers visiting some tropical areas and countries, such as Nepal, the Caribbean, Peru and Mexico. More rarely this enteric pathogen affects immunocompromised humans, namely HIV-infected people or AIDS patients, with some clinical pictures recognized in normal hosts. We describe the first case of Cyclospora sp. and Cryptosporidium parvum associated diarrhoeal enteritis in an adult AIDS patient.


Subject(s)
AIDS-Related Opportunistic Infections/parasitology , Coccidiosis/complications , Cryptosporidiosis/complications , Cryptosporidium parvum/isolation & purification , Diarrhea/parasitology , Eucoccidiida/isolation & purification , Adult , Animals , Coccidiosis/parasitology , Cryptosporidiosis/parasitology , Feces/parasitology , Humans , Male
20.
Haematologica ; 78(1): 34-7, 1993.
Article in English | MEDLINE | ID: mdl-7684010

ABSTRACT

BACKGROUND: The association between lymphoproliferative disease and AIDS is now well known, but only non-Hodgkin's lymphomas (LNH) are surely related to HIV infection. Hodgkin's disease (HD) occurs rarely in HIV seropositives, so it is impossible to establish a connection between AIDS and this neoplasm. METHODS AND RESULT: We describe nine cases of HIV seropositive patients who developed HD in different stages of the HIV infection. We carefully examine clinical course and response to therapy in these patients, above all paying attention to opportunistic infections (OI) and progression to full-blown AIDS. CONCLUSION: Finally, we discuss the possibility of including HD among the definition criteria for AIDS.


Subject(s)
HIV Infections/complications , Hodgkin Disease/complications , AIDS-Related Opportunistic Infections/complications , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/administration & dosage , Dacarbazine/administration & dosage , Doxorubicin/administration & dosage , Epirubicin/administration & dosage , Female , Hodgkin Disease/drug therapy , Hodgkin Disease/mortality , Hodgkin Disease/pathology , Humans , Male , Mechlorethamine/administration & dosage , Prednisone/administration & dosage , Procarbazine/administration & dosage , Remission Induction , Vinblastine/administration & dosage , Vincristine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...